HCA Stock Balance Sheets

HCA Healthcare Quarterly Balance Sheets Chart

Quarterly

Annual

Account Receivables

Cash and Cash Eq

Account Payables

Inventory

HCA Healthcare Quarterly Balance Sheets Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2017-03-31	2016-12-31	2016-09-30	2016-06-30	2016-03-31	2015-12-31	2015-09-30	2015-06-30	2015-03-31	2014-12-31	2014-09-30	2014-06-30	2014-03-31	2013-12-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2010-03-31	2009-12-31	2009-09-30	2009-06-30	2009-03-31

assets
current assets:
cash and cash equivalents	939,000,000	1,060,000,000	1,933,000,000	2,888,000,000	831,000,000	1,284,000,000	935,000,000	891,000,000	862,000,000	842,000,000	908,000,000	999,000,000	858,000,000	2,371,000,000	1,451,000,000	1,027,000,000	1,120,000,000	1,030,000,000	1,793,000,000	6,588,000,000	4,638,000,000	731,000,000	621,000,000	559,000,000	2,430,000,000	531,000,000	502,000,000	578,000,000	868,000,000	1,086,000,000	732,000,000	718,000,000	705,000,000	753,000,000	646,000,000	677,000,000	691,000,000	852,000,000	741,000,000	588,000,000	673,000,000	586,000,000	566,000,000	515,000,000	658,000,000	850,000,000	414,000,000	484,000,000	462,000,000	594,000,000	705,000,000	472,000,000	518,000,000	471,000,000	373,000,000	359,000,000	539,000,000	553,000,000	411,000,000	377,000,000	350,000,000	388,000,000	312,000,000	443,000,000	450,000,000	356,000,000
accounts receivable	10,459,000,000	11,088,000,000	10,751,000,000	9,915,000,000	10,239,000,000	10,044,000,000	9,958,000,000	9,182,000,000	8,713,000,000	8,657,000,000	8,891,000,000	8,552,000,000	8,628,000,000	8,520,000,000	8,095,000,000	8,433,000,000	7,636,000,000	7,424,000,000	7,051,000,000	6,433,000,000	6,139,000,000	6,890,000,000	7,380,000,000	7,131,000,000	7,219,000,000	7,420,000,000	6,789,000,000	6,532,000,000	6,592,000,000	6,332,000,000		-3,174,000,000	-1,752,000,000	-592,000,000		-2,044,000,000	-1,364,000,000	-789,000,000		-2,976,000,000	-1,784,000,000	-895,000,000
inventories	1,792,000,000	1,794,000,000	1,738,000,000	1,776,000,000	1,800,000,000	1,903,000,000	2,021,000,000	2,030,000,000	2,050,000,000	2,085,000,000	2,068,000,000	2,009,000,000	2,043,000,000	2,003,000,000	1,986,000,000	2,019,000,000	2,027,000,000	2,068,000,000	2,025,000,000	1,950,000,000	1,834,000,000	1,953,000,000	1,849,000,000	1,769,000,000	1,826,000,000	1,778,000,000	1,732,000,000	1,634,000,000	1,636,000,000	1,677,000,000	1,573,000,000	1,546,000,000	1,544,000,000	1,501,000,000	1,503,000,000	1,503,000,000	1,481,000,000	1,415,000,000	1,439,000,000	1,379,000,000	1,348,000,000	1,287,000,000	1,279,000,000	1,258,000,000	1,211,000,000	1,187,000,000	1,179,000,000	1,135,000,000	1,152,000,000	1,104,000,000	1,086,000,000	1,052,000,000	1,055,000,000	1,046,000,000	1,054,000,000	891,000,000	887,000,000	881,000,000	897,000,000	815,000,000	805,000,000	794,000,000	802,000,000	745,000,000	730,000,000	717,000,000
other	2,373,000,000	2,316,000,000	1,992,000,000	2,083,000,000	2,303,000,000	2,051,000,000	2,013,000,000	2,191,000,000	2,263,000,000	1,957,000,000	1,776,000,000	1,921,000,000	2,408,000,000	2,112,000,000	2,010,000,000	1,769,000,000	1,692,000,000	1,514,000,000	1,464,000,000	1,295,000,000	1,420,000,000	1,442,000,000	1,346,000,000	1,310,000,000	1,394,000,000	1,379,000,000	1,190,000,000	1,266,000,000	1,298,000,000	1,296,000,000	1,171,000,000	1,204,000,000	1,306,000,000	1,119,000,000	1,111,000,000	1,160,000,000	1,254,000,000	1,054,000,000	1,163,000,000	1,015,000,000	1,092,000,000	1,025,000,000	1,025,000,000	910,000,000	931,000,000	859,000,000	747,000,000	828,000,000	861,000,000	827,000,000	915,000,000	828,000,000	756,000,000	661,000,000	679,000,000	875,000,000	625,000,000	576,000,000	848,000,000	678,000,000	742,000,000	497,000,000	579,000,000	515,000,000	556,000,000	558,000,000
property and equipment, at cost	64,388,000,000	63,680,000,000		61,750,000,000	60,625,000,000	59,440,000,000		57,772,000,000	56,667,000,000	55,463,000,000		53,730,000,000	52,816,000,000	52,042,000,000		50,695,000,000	50,698,000,000	49,877,000,000		48,775,000,000	48,484,000,000	47,861,000,000		46,295,000,000	45,369,000,000	44,583,000,000		41,978,000,000	41,142,000,000	40,308,000,000		39,262,000,000	38,306,000,000	37,588,000,000		36,449,000,000	35,873,000,000	34,978,000,000		34,207,000,000	33,803,000,000	33,293,000,000		32,301,000,000	31,841,000,000	31,369,000,000		30,472,000,000	30,077,000,000	29,764,000,000		29,145,000,000	28,742,000,000	28,354,000,000		26,647,000,000	26,338,000,000	25,855,000,000		25,226,000,000	24,950,000,000	24,766,000,000		24,389,000,000	24,185,000,000	23,913,000,000
accumulated depreciation	-34,265,000,000	-33,942,000,000	-33,100,000,000	-32,703,000,000	-31,986,000,000	-31,344,000,000	-30,833,000,000	-30,655,000,000	-30,023,000,000	-29,410,000,000	-29,182,000,000	-28,752,000,000	-28,229,000,000	-27,814,000,000	-27,287,000,000	-27,148,000,000	-27,227,000,000	-26,689,000,000	-26,118,000,000	-25,834,000,000	-25,413,000,000	-24,876,000,000	-24,520,000,000	-24,293,000,000	-23,902,000,000	-23,455,000,000	-23,208,000,000	-22,937,000,000	-22,598,000,000	-22,184,000,000	-22,189,000,000	-21,933,000,000	-21,538,000,000	-21,126,000,000	-20,703,000,000	-20,574,000,000	-20,249,000,000	-19,921,000,000	-19,600,000,000	-19,503,000,000	-19,243,000,000	-18,901,000,000	-18,625,000,000	-18,423,000,000	-18,120,000,000	-17,757,000,000	-17,454,000,000	-17,150,000,000	-16,848,000,000	-16,620,000,000	-16,342,000,000	-16,185,000,000	-15,896,000,000	-15,567,000,000	-15,241,000,000	-15,002,000,000	-14,754,000,000	-14,508,000,000	-14,289,000,000	-14,090,000,000	-13,798,000,000	-13,514,000,000	-13,242,000,000	-13,038,000,000	-12,752,000,000	-12,458,000,000
investments of insurance subsidiaries	531,000,000	550,000,000	569,000,000	553,000,000	483,000,000	471,000,000	477,000,000	382,000,000	384,000,000	390,000,000	381,000,000	372,000,000	379,000,000	408,000,000	438,000,000	418,000,000	410,000,000	393,000,000	388,000,000	390,000,000	364,000,000	325,000,000	315,000,000	357,000,000	342,000,000	338,000,000	362,000,000	367,000,000	414,000,000	417,000,000	418,000,000	368,000,000	352,000,000	349,000,000	336,000,000	354,000,000	341,000,000	425,000,000	432,000,000	409,000,000	404,000,000	435,000,000	494,000,000	441,000,000	426,000,000	453,000,000	448,000,000	402,000,000	405,000,000	423,000,000	515,000,000	473,000,000	495,000,000	536,000,000	548,000,000
investments in and advances to affiliates	654,000,000	657,000,000	662,000,000	705,000,000	702,000,000	736,000,000	756,000,000	739,000,000	731,000,000	786,000,000	823,000,000	444,000,000	435,000,000	441,000,000	448,000,000	412,000,000	382,000,000	427,000,000	422,000,000	335,000,000	275,000,000	238,000,000	249,000,000	243,000,000	247,000,000	246,000,000	232,000,000	238,000,000	234,000,000	231,000,000	199,000,000	201,000,000	197,000,000	194,000,000	206,000,000	216,000,000	201,000,000	174,000,000	178,000,000	186,000,000	182,000,000	181,000,000	165,000,000	167,000,000	150,000,000	142,000,000	121,000,000	125,000,000	120,000,000	107,000,000	104,000,000	103,000,000	102,000,000	108,000,000	101,000,000	837,000,000	843,000,000	852,000,000	869,000,000	857,000,000	870,000,000	851,000,000	853,000,000	855,000,000	854,000,000	860,000,000
goodwill and other intangible assets	10,273,000,000	10,237,000,000	10,093,000,000	9,982,000,000	9,963,000,000	9,967,000,000	9,945,000,000	9,778,000,000	9,641,000,000	9,590,000,000	9,653,000,000	9,651,000,000	9,593,000,000	9,525,000,000	9,540,000,000	9,153,000,000	8,680,000,000	8,575,000,000	8,578,000,000	8,570,000,000	8,578,000,000	8,587,000,000	8,269,000,000	8,160,000,000	8,140,000,000	8,159,000,000	7,953,000,000	7,759,000,000	7,459,000,000	7,471,000,000	7,394,000,000	7,357,000,000	6,771,000,000	6,754,000,000	6,704,000,000	6,691,000,000	6,694,000,000	6,713,000,000	6,731,000,000	6,540,000,000	6,484,000,000	6,415,000,000	6,416,000,000	5,899,000,000	5,909,000,000	5,910,000,000	5,903,000,000	5,832,000,000	5,534,000,000	5,541,000,000	5,539,000,000	5,460,000,000	5,431,000,000	5,398,000,000	5,251,000,000
right-of-use operating lease assets	2,156,000,000	2,132,000,000	2,131,000,000	2,201,000,000	2,179,000,000	2,211,000,000	2,207,000,000	2,079,000,000	2,110,000,000	2,032,000,000	2,065,000,000	2,097,000,000	2,139,000,000	2,138,000,000	2,113,000,000	2,099,000,000	2,118,000,000	2,083,000,000	2,024,000,000	1,972,000,000	1,863,000,000	1,828,000,000	1,834,000,000	1,770,000,000	1,787,000,000	1,812,000,000
liabilities and stockholders’ (deficit) equity
current liabilities:
accounts payable	4,250,000,000	4,488,000,000	4,276,000,000	4,235,000,000	4,029,000,000	4,735,000,000	4,233,000,000	4,139,000,000	3,823,000,000	3,769,000,000	4,239,000,000	4,161,000,000	3,742,000,000	4,010,000,000	4,111,000,000	3,759,000,000	3,531,000,000	3,524,000,000	3,535,000,000	3,270,000,000	2,882,000,000	2,750,000,000	2,905,000,000	2,610,000,000	2,609,000,000	2,693,000,000	2,577,000,000	2,414,000,000	2,457,000,000	2,538,000,000	2,606,000,000	2,314,000,000	2,245,000,000	2,233,000,000	2,318,000,000	1,950,000,000	1,934,000,000	1,944,000,000	2,170,000,000	1,877,000,000	1,884,000,000	1,973,000,000	2,035,000,000	1,787,000,000	1,717,000,000	1,735,000,000	1,803,000,000	1,582,000,000	1,657,000,000	1,691,000,000	1,768,000,000	1,585,000,000	1,517,000,000	1,412,000,000	1,597,000,000	1,334,000,000	1,297,000,000	1,348,000,000	1,537,000,000	1,254,000,000	1,179,000,000	1,199,000,000	1,460,000,000	1,199,000,000	1,206,000,000	1,200,000,000
accrued salaries	2,072,000,000	1,857,000,000	2,304,000,000	2,164,000,000	1,993,000,000	1,759,000,000	2,127,000,000	1,912,000,000	1,776,000,000	1,565,000,000	1,712,000,000	1,625,000,000	1,895,000,000	1,865,000,000	1,912,000,000	2,134,000,000	1,896,000,000	1,767,000,000	1,720,000,000	1,971,000,000	1,631,000,000	1,560,000,000	1,775,000,000	1,669,000,000	1,497,000,000	1,424,000,000	1,580,000,000	1,456,000,000	1,315,000,000	1,238,000,000	1,369,000,000	1,312,000,000	1,209,000,000	1,150,000,000	1,265,000,000	1,241,000,000	1,405,000,000	1,309,000,000	1,233,000,000	1,358,000,000	1,282,000,000	1,180,000,000	1,370,000,000	1,238,000,000	1,140,000,000	1,052,000,000	1,193,000,000	1,085,000,000	1,036,000,000	969,000,000	1,120,000,000	1,027,000,000	970,000,000	909,000,000	965,000,000	876,000,000	1,009,000,000	975,000,000	895,000,000	1,007,000,000	927,000,000	893,000,000	849,000,000	954,000,000	876,000,000	823,000,000
other accrued expenses	4,513,000,000	3,767,000,000	3,899,000,000	3,819,000,000	3,705,000,000	3,619,000,000	3,871,000,000	3,803,000,000	3,551,000,000	3,316,000,000	3,581,000,000	3,780,000,000	3,116,000,000	3,157,000,000	3,322,000,000	3,481,000,000	2,935,000,000	3,117,000,000	3,240,000,000	2,843,000,000	3,181,000,000	2,547,000,000	2,932,000,000	2,697,000,000	2,782,000,000	2,618,000,000	2,624,000,000	2,170,000,000	2,161,000,000	2,005,000,000	1,983,000,000	1,783,000,000	2,104,000,000	1,868,000,000	2,035,000,000	1,748,000,000	1,833,000,000	1,919,000,000	1,880,000,000	1,701,000,000	1,770,000,000	1,982,000,000	1,737,000,000	1,563,000,000	1,992,000,000	2,063,000,000	1,913,000,000	1,764,000,000	1,871,000,000	1,893,000,000	1,849,000,000	1,498,000,000	1,651,000,000	1,453,000,000	1,585,000,000	1,336,000,000	1,283,000,000	1,398,000,000	1,245,000,000	1,373,000,000	1,262,000,000	1,498,000,000	1,158,000,000	1,316,000,000	1,119,000,000	1,458,000,000
short-term borrowings and long-term debt due within one year	5,104,000,000
long-term debt, less debt issuance costs and discounts of 429 and 369	39,379,000,000
professional liability risks	1,506,000,000	1,497,000,000	1,544,000,000	1,584,000,000	1,573,000,000	1,571,000,000	1,557,000,000	1,590,000,000	1,554,000,000	1,565,000,000	1,528,000,000	1,510,000,000	1,533,000,000	1,508,000,000	1,514,000,000	1,522,000,000	1,585,000,000	1,553,000,000	1,486,000,000	1,434,000,000	1,485,000,000	1,432,000,000	1,370,000,000	1,349,000,000	1,354,000,000	1,313,000,000	1,275,000,000	1,239,000,000	1,283,000,000	1,244,000,000	1,198,000,000	1,179,000,000	1,144,000,000	1,134,000,000	1,148,000,000	1,164,000,000	1,126,000,000	1,116,000,000	1,115,000,000	1,117,000,000	1,132,000,000	1,095,000,000	1,078,000,000	1,045,000,000	1,019,000,000	978,000,000	949,000,000	959,000,000	960,000,000	970,000,000	973,000,000	962,000,000	1,039,000,000	1,030,000,000	993,000,000	993,000,000	987,000,000	1,003,000,000	995,000,000	1,027,000,000	1,029,000,000	1,058,000,000	1,057,000,000	1,097,000,000	1,108,000,000	1,098,000,000
right-of-use operating lease obligations	1,881,000,000	1,860,000,000	1,863,000,000	1,924,000,000	1,894,000,000	1,912,000,000	1,903,000,000	1,776,000,000	1,806,000,000	1,716,000,000	1,752,000,000	1,762,000,000	1,796,000,000	1,790,000,000	1,755,000,000	1,742,000,000	1,767,000,000	1,730,000,000	1,673,000,000	1,635,000,000	1,531,000,000	1,497,000,000	1,499,000,000	1,440,000,000	1,460,000,000	1,494,000,000
income taxes and other liabilities	2,069,000,000	2,191,000,000	2,041,000,000	1,982,000,000	1,966,000,000	1,905,000,000	1,867,000,000	1,666,000,000	1,691,000,000	1,692,000,000	1,615,000,000	1,714,000,000	1,741,000,000	1,768,000,000	2,060,000,000	2,800,000,000	2,088,000,000	2,032,000,000	1,940,000,000	1,477,000,000	1,490,000,000	1,477,000,000	1,420,000,000	1,349,000,000	1,324,000,000	1,277,000,000	1,248,000,000	1,388,000,000	1,459,000,000	1,417,000,000	1,374,000,000	1,256,000,000	1,282,000,000	1,253,000,000	1,249,000,000	1,746,000,000	1,953,000,000	1,933,000,000	1,904,000,000	1,903,000,000	1,860,000,000	1,837,000,000	1,832,000,000	1,740,000,000	1,554,000,000	1,524,000,000	1,525,000,000	1,670,000,000	1,695,000,000	1,763,000,000	1,776,000,000	1,860,000,000	1,857,000,000	1,757,000,000	1,720,000,000	1,683,000,000	1,515,000,000	1,507,000,000	1,608,000,000	1,611,000,000	1,589,000,000	1,742,000,000	1,768,000,000	1,782,000,000	1,713,000,000	1,853,000,000
stockholders’ (deficit) equity:
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 236,143,900 shares — 2025 and 249,981,400 shares — 2024	2,000,000
accumulated other comprehensive loss	-309,000,000	-357,000,000	-387,000,000	-378,000,000	-433,000,000	-433,000,000	-425,000,000	-491,000,000	-456,000,000	-470,000,000	-490,000,000	-592,000,000	-515,000,000	-447,000,000	-404,000,000	-492,000,000	-475,000,000	-491,000,000	-502,000,000	-515,000,000	-562,000,000	-571,000,000	-460,000,000	-461,000,000	-431,000,000	-374,000,000	-381,000,000	-266,000,000	-261,000,000	-197,000,000	-278,000,000	-268,000,000	-293,000,000	-320,000,000	-338,000,000	-341,000,000	-344,000,000	-294,000,000	-265,000,000	-309,000,000	-290,000,000	-344,000,000	-323,000,000	-206,000,000	-199,000,000	-232,000,000	-257,000,000	-374,000,000	-426,000,000	-475,000,000	-457,000,000	-440,000,000	-449,000,000	-411,000,000	-440,000,000	-424,000,000	-339,000,000	-344,000,000	-428,000,000	-494,000,000	-505,000,000	-479,000,000	-450,000,000	-505,000,000	-498,000,000	-608,000,000
retained deficit	-4,087,000,000	-3,164,000,000	-2,115,000,000	-1,807,000,000	-1,170,000,000	-1,185,000,000	-1,352,000,000	-1,989,000,000	-1,850,000,000	-2,028,000,000	-2,280,000,000	-2,781,000,000	-3,168,000,000	-1,589,000,000						-647,000,000	-1,315,000,000	-2,394,000,000	-2,351,000,000	-3,107,000,000	-3,474,000,000	-3,983,000,000	-4,572,000,000	-5,342,000,000	-5,731,000,000	-6,051,000,000	-6,532,000,000	-6,516,000,000	-6,503,000,000	-6,701,000,000	-6,968,000,000	-7,426,000,000	-7,767,000,000	-7,266,000,000	-7,338,000,000	-6,989,000,000	-7,120,000,000	-7,280,000,000	-7,575,000,000	-8,054,000,000	-8,572,000,000	-9,055,000,000	-9,403,000,000	-9,827,000,000	-10,193,000,000	-10,616,000,000	-10,960,000,000	-9,103,000,000	-9,463,000,000	-9,854,000,000	-9,423,000,000	-11,358,000,000	-11,419,000,000	-11,648,000,000	-11,888,000,000	-10,090,000,000	-10,333,000,000	-10,126,000,000	-8,763,000,000	-8,979,000,000	-9,175,000,000	-9,457,000,000
stockholders’ deficit attributable to hca healthcare, inc.	-4,394,000,000	-3,519,000,000	-2,499,000,000	-2,182,000,000	-1,600,000,000	-1,615,000,000	-1,774,000,000	-2,477,000,000	-2,303,000,000	-2,495,000,000	-2,767,000,000	-3,370,000,000	-3,680,000,000	-2,033,000,000						-974,000,000	-1,786,000,000	-2,962,000,000	-2,808,000,000	-3,565,000,000	-3,902,000,000	-4,354,000,000	-4,950,000,000	-5,605,000,000	-5,989,000,000	-6,244,000,000	-6,806,000,000	-6,780,000,000	-6,792,000,000	-7,017,000,000
noncontrolling interests	3,156,000,000	3,081,000,000	3,054,000,000	2,968,000,000	2,939,000,000	2,885,000,000	2,834,000,000	2,834,000,000	2,764,000,000	2,727,000,000	2,694,000,000	2,592,000,000	2,538,000,000	2,447,000,000	2,422,000,000	2,520,000,000	2,383,000,000	2,235,000,000	2,320,000,000	2,273,000,000	2,354,000,000	2,259,000,000	2,243,000,000	2,118,000,000	2,132,000,000	2,099,000,000	2,032,000,000	1,875,000,000	1,864,000,000	1,810,000,000	1,811,000,000	1,714,000,000	1,713,000,000	1,660,000,000	1,669,000,000	1,600,000,000	1,609,000,000	1,557,000,000	1,553,000,000	1,482,000,000	1,451,000,000	1,398,000,000	1,396,000,000	1,366,000,000	1,402,000,000	1,361,000,000	1,342,000,000	1,332,000,000	1,338,000,000	1,311,000,000	1,319,000,000	1,296,000,000	1,300,000,000	1,289,000,000	1,244,000,000	1,132,000,000	1,147,000,000	1,142,000,000	1,132,000,000	1,017,000,000	1,017,000,000	1,015,000,000	1,008,000,000	990,000,000	1,005,000,000	1,019,000,000
long-term debt due within one year		3,519,000,000	4,698,000,000	4,682,000,000	4,574,000,000	3,028,000,000	2,424,000,000	2,553,000,000	2,395,000,000	2,378,000,000	370,000,000	218,000,000	246,000,000	1,486,000,000	237,000,000	250,000,000	253,000,000	234,000,000	209,000,000	172,000,000	163,000,000	162,000,000	145,000,000	148,000,000	2,073,000,000	3,796,000,000	788,000,000	191,000,000	1,692,000,000	1,697,000,000	200,000,000	202,000,000	213,000,000	212,000,000	216,000,000	216,000,000	224,000,000	226,000,000	233,000,000	1,377,000,000	1,374,000,000	2,037,000,000	338,000,000	1,044,000,000	1,046,000,000	1,041,000,000	786,000,000	988,000,000	1,456,000,000	1,438,000,000	1,435,000,000	1,751,000,000	1,309,000,000	1,841,000,000	1,407,000,000	725,000,000	689,000,000	546,000,000	592,000,000	696,000,000	1,029,000,000	981,000,000	846,000,000	635,000,000	194,000,000	416,000,000
long-term debt, less debt issuance costs and discounts of 432 and 369		41,057,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 242,955,400 shares — 2025 and 249,981,400 shares — 2024		2,000,000
property and equipment, at cost:
land			3,295,000,000				3,120,000,000				2,799,000,000				2,496,000,000				2,269,000,000				2,178,000,000				1,944,000,000				1,746,000,000				1,611,000,000				1,524,000,000				1,524,000,000				1,487,000,000				1,429,000,000				1,416,000,000				1,215,000,000				1,202,000,000
buildings			22,691,000,000				21,560,000,000				20,221,000,000				19,211,000,000				18,471,000,000				17,669,000,000				15,659,000,000				14,249,000,000				13,546,000,000				12,533,000,000				11,941,000,000				11,211,000,000				10,720,000,000				10,231,000,000				9,438,000,000				9,108,000,000
equipment			34,670,000,000				31,998,000,000				29,981,000,000				28,256,000,000				27,082,000,000				25,756,000,000				23,577,000,000				22,168,000,000				20,580,000,000				19,335,000,000				18,496,000,000				17,519,000,000				16,430,000,000				15,431,000,000				14,310,000,000				13,575,000,000
construction in progress			1,858,000,000				1,870,000,000				1,756,000,000				1,387,000,000				1,495,000,000				1,632,000,000				1,785,000,000				1,921,000,000				1,318,000,000				1,222,000,000				1,019,000,000				856,000,000				948,000,000				997,000,000				678,000,000				784,000,000
liabilities and stockholders’ equity
long-term debt, less debt issuance costs and discounts of 369 and 333			38,333,000,000
stockholders’ equity
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 249,981,400 shares — 2024 and 265,537,300 shares — 2023			3,000,000
long-term debt, less debt issuance costs and discounts of 378 and 333				38,283,000,000
stockholders’ equity:
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 254,517,700 shares — 2024 and 265,537,300 shares — 2023				3,000,000
long-term debt, less debt issuance costs and discounts of 371 and 333					36,306,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 259,237,600 shares — 2024 and 265,537,300 shares — 2023					3,000,000
long-term debt, less debt issuance costs and discounts of 381 and 333						37,163,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 263,215,800 shares — 2024 and 265,537,300 shares — 2023						3,000,000
long-term debt, less debt issuance costs and discounts of 333 and 301							37,169,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 265,537,300 shares — 2023 and 277,378,300 shares — 2022							3,000,000
long-term debt, less debt issuance costs and discounts of 341 and 301								36,793,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 268,967,300 shares — 2023 and 277,378,300 shares — 2022								3,000,000
long-term debt, less debt issuance costs and discounts of 349 and 301									36,537,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 272,931,700 shares — 2023 and 277,378,300 shares — 2022									3,000,000
long-term debt, less debt issuance costs and discounts of 295 and 301										36,478,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 275,939,900 shares — 2023 and 277,378,300 shares — 2022										3,000,000
long-term debt, less debt issuance costs and discounts of 301 and 248											37,714,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 277,378,300 shares — 2022 and 305,476,800 shares — 2021											3,000,000
long-term debt, less debt issuance costs and discounts of 309 and 248												37,492,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 283,903,500 shares — 2022 and 305,476,800 shares — 2021												3,000,000
long-term debt, less debt issuance costs and discounts of 316 and 248													38,657,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 287,004,400 shares — 2022 and 305,476,800 shares — 2021													3,000,000
long-term debt, less debt issuance costs and discounts of 323 and 248														36,210,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 298,980,900 shares — 2022 and 305,476,800 shares — 2021														3,000,000
long-term debt, less debt issuance costs and discounts of 248 and 236															34,342,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 305,476,800 shares — 2021 and 339,425,600 shares — 2020															3,000,000
capital in excess of par value																			294,000,000	185,000,000	88,000,000																							872,000,000	777,000,000	1,455,000,000	1,386,000,000	1,821,000,000	1,792,000,000	1,764,000,000	1,753,000,000	1,680,000,000	1,665,000,000	1,648,000,000	1,601,000,000	1,584,000,000	3,072,000,000	3,057,000,000	389,000,000	324,000,000	312,000,000	291,000,000	226,000,000	204,000,000	186,000,000	176,000,000
retained earnings															-532,000,000			735,000,000	777,000,000
stockholders’ equity (deficit) attributable to hca healthcare, inc.															-933,000,000				572,000,000
long-term debt, less debt issuance costs and discounts of 253 and 236																32,049,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 313,502,400 shares — 2021 and 339,425,600 shares — 2020																3,000,000
retained (deficit) earnings																-206,000,000	-121,000,000
stockholders’ (deficit) equity attributable to hca healthcare, inc.																-695,000,000	-593,000,000
long-term debt, less debt issuance costs and discounts of 255 and 236																	32,319,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 322,824,800 shares — 2021 and 339,425,600 shares — 2020																	3,000,000
long-term debt, less debt issuance costs and discounts of 229 and 236																		30,838,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 333,714,500 shares — 2021 and 339,425,600 shares — 2020																		3,000,000
stockholders’ equity attributable to hca healthcare, inc.																		247,000,000
long-term debt, less debt issuance costs and discounts of 236 and 239																			30,795,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 339,425,600 shares — 2020 and 338,445,600 shares — 2019																			3,000,000
government stimulus refund liability																				6,123,000,000
long-term debt, less debt issuance costs and discounts of 245 and 239																				30,792,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 338,370,500 shares in 2020 and 338,445,600 shares in 2019																				3,000,000
liabilities and stockholders’ deficit
contract liabilities-deferred revenues																					4,999,000,000
long-term debt, less debt issuance costs and discounts of 252 and 239																					30,779,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 337,960,400 shares in 2020 and 338,445,600 shares in 2019																					3,000,000
long-term debt, less debt issuance costs and discounts of 258 and 239																						34,699,000,000
stockholders’ deficit:
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 337,607,500 shares in 2020 and 338,445,600 shares in 2019																						3,000,000
long-term debt, less debt issuance costs and discounts of 239 and 157																							33,577,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 338,445,600 shares — 2019 and 342,895,200 shares — 2018																							3,000,000
long-term debt, less debt issuance costs and discounts of 244 and 157																								34,097,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 340,053,100 shares in 2019 and 342,895,200 shares in 2018																								3,000,000
long-term debt, less debt issuance costs and discounts of 252 and 157																									34,120,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 341,516,800 shares in 2019 and 342,895,200 shares in 2018																									3,000,000
long-term debt, less net debt issuance costs of 170 and 157																										31,019,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 343,030,500 shares in 2019 and 342,895,200 shares in 2018																										3,000,000
long-term debt, less net debt issuance costs of 157 and 164																											32,033,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 342,895,200 shares—2018 and 350,091,600 shares—2017																											3,000,000
balances, december 31, 2015																											398,739,000				398,739,000				398,739,000				398,739,000
comprehensive income
repurchase of common stock																											-36,325,000	-5,121,000			-31,991,000				-28,583,000				-10,656,000				-10,656,000,000	-750,000,000	-750,000,000		-80,771,000,000				-80,771,000,000
share-based benefit plans																											8,122,000	3,280,000			10,252,000				9,457,000				7,060,000				5,722,000,000				3,071,000,000				1,118,000,000
distributions
balances, december 31, 2016																											370,536,000	370,536,000			370,536,000				370,536,000
acquisition of entities with noncontrolling interests
balances, december 31, 2017																											350,092,000	350,092,000			350,092,000
cash dividends declared
net acquisition of entities with noncontrolling interests
reclassification of stranded tax effects
balances, december 31, 2018																											342,895,000
long-term debt, less net debt issuance costs of 163 and 164																												32,916,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 345,085,800 shares in 2018 and 350,091,600 shares in 2017																												3,000,000
balances, march 31, 2017																												368,695,000
balances, june 30, 2017																												362,895,000
balances, september 30, 2017																												356,980,000
balances, march 31, 2018																												350,987,000
balances, june 30, 2018																												346,760,000
balances, september 30, 2018																												345,086,000
long-term debt, less net debt issuance costs of 151 and 164																													31,500,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 346,760,200 shares in 2018 and 350,091,600 shares in 2017																													3,000,000
cash flows from operating activities:
net income																													2,248,000,000	1,282,000,000		2,102,000,000	1,572,000,000	777,000,000		2,347,000,000	1,602,000,000	811,000,000		1,958,000,000	1,385,000,000	720,000,000		1,697,000,000	1,086,000,000	454,000,000		1,442,000,000	975,000,000	438,000,000		1,579,000,000	1,124,000,000	639,000,000
adjustments to reconcile net income to net cash from operating activities:
increase in cash from operating assets and liabilities:
inventories and other assets																													-200,000,000	-218,000,000		-50,000,000	-178,000,000	3,000,000		-161,000,000	-176,000,000	14,000,000		-205,000,000	-195,000,000	-106,000,000
accounts payable and accrued expenses																													31,000,000	-246,000,000		-169,000,000	-298,000,000	-591,000,000		-341,000,000	-102,000,000	-371,000,000		-152,000,000	-117,000,000	-312,000,000
depreciation and amortization																													1,115,000,000	553,000,000		1,581,000,000	1,042,000,000	521,000,000		1,463,000,000	968,000,000	479,000,000		1,424,000,000	942,000,000	473,000,000		1,361,000,000	901,000,000	447,000,000		1,292,000,000	849,000,000	424,000,000		1,254,000,000	837,000,000	417,000,000
income taxes																													118,000,000	246,000,000		-9,000,000	267,000,000	292,000,000		8,000,000	67,000,000	360,000,000		-148,000,000	-101,000,000	438,000,000		-61,000,000	-94,000,000	144,000,000		158,000,000	183,000,000	350,000,000		250,000,000	326,000,000	300,000,000
gains on sales of facilities																													-414,000,000	-405,000,000		-10,000,000	-3,000,000			-8,000,000	-5,000,000			-2,000,000	-4,000,000	-9,000,000
amortization of debt issuance costs																													15,000,000	8,000,000		23,000,000	16,000,000	8,000,000		26,000,000	18,000,000	10,000,000		27,000,000	19,000,000	10,000,000
share-based compensation																													134,000,000	60,000,000		195,000,000	140,000,000	73,000,000		196,000,000	129,000,000	65,000,000		171,000,000	103,000,000	48,000,000		118,000,000	77,000,000	37,000,000		81,000,000	51,000,000	23,000,000		39,000,000	23,000,000	9,000,000
net cash from operating activities																													2,865,000,000	1,300,000,000		3,692,000,000	2,684,000,000	1,280,000,000		3,954,000,000	2,748,000,000	1,399,000,000		3,176,000,000	2,075,000,000	1,018,000,000		2,821,000,000	1,693,000,000	443,000,000		2,454,000,000	1,554,000,000	740,000,000		2,912,000,000	2,257,000,000	797,000,000
cash flows from investing activities:
purchase of property and equipment																													-1,574,000,000	-694,000,000		-2,033,000,000	-1,304,000,000	-571,000,000		-1,884,000,000	-1,172,000,000	-509,000,000		-1,571,000,000	-1,004,000,000	-446,000,000		-1,482,000,000	-913,000,000	-400,000,000		-1,347,000,000	-896,000,000	-404,000,000		-1,268,000,000	-784,000,000	-335,000,000
acquisition of hospitals and health care entities																													-538,000,000	-379,000,000		-1,142,000,000	-295,000,000	-90,000,000		-468,000,000	-430,000,000	-9,000,000		-184,000,000	-95,000,000	-28,000,000		-97,000,000	-27,000,000	-19,000,000		-463,000,000	-23,000,000	-22,000,000		-167,000,000	-139,000,000	-112,000,000
disposal of hospitals and health care entities																													799,000,000	767,000,000		24,000,000	14,000,000	4,000,000		23,000,000	14,000,000	4,000,000		27,000,000	22,000,000	15,000,000
change in investments																													23,000,000	11,000,000		-15,000,000	-11,000,000	-19,000,000		78,000,000	18,000,000	11,000,000		94,000,000	67,000,000	22,000,000		22,000,000	43,000,000	-13,000,000		97,000,000	102,000,000	51,000,000		73,000,000	35,000,000	6,000,000
net cash from investing activities																													-1,315,000,000	-335,000,000		-3,172,000,000	-1,591,000,000	-669,000,000		-2,234,000,000	-1,555,000,000	-496,000,000		-1,631,000,000	-1,009,000,000	-432,000,000		-1,512,000,000	-864,000,000	-409,000,000		-1,674,000,000	-790,000,000	-373,000,000		-1,340,000,000	-886,000,000	-437,000,000
cash flows from financing activities:
issuances of long-term debt																																1,502,000,000	1,502,000,000			5,400,000,000	3,000,000,000	3,000,000,000		4,048,000,000	4,048,000,000	1,000,000,000
net change in revolving bank credit facilities																													210,000,000	270,000,000		650,000,000	-1,160,000,000	160,000,000		-70,000,000		-930,000,000		-270,000,000	-300,000,000	-260,000,000
repayment of long-term debt																													-101,000,000	-50,000,000		-700,000,000	-95,000,000	-43,000,000		-4,424,000,000	-2,065,000,000	-2,011,000,000		-3,702,000,000	-3,644,000,000	-791,000,000		-3,525,000,000	-3,482,000,000	-542,000,000		-1,300,000,000	-768,000,000	-741,000,000		-689,000,000	-608,000,000	-93,000,000
distributions to noncontrolling interests																													-185,000,000	-92,000,000		-363,000,000	-248,000,000	-145,000,000		-342,000,000	-205,000,000	-111,000,000		-367,000,000	-237,000,000	-132,000,000		-325,000,000	-197,000,000	-87,000,000		-308,000,000	-196,000,000	-102,000,000		-303,000,000	-191,000,000	-93,000,000
payment of debt issuance costs																													-2,000,000	-2,000,000		-25,000,000	-25,000,000	-2,000,000		-40,000,000	-24,000,000	-22,000,000		-34,000,000	-33,000,000	-11,000,000		-49,000,000	-49,000,000	-48,000,000		-5,000,000	-5,000,000			-20,000,000	-19,000,000	-16,000,000
payment of cash dividends																													-245,000,000	-123,000,000
repurchases of common stock																													-893,000,000	-423,000,000		-1,475,000,000	-966,000,000	-424,000,000		-2,213,000,000	-1,858,000,000	-621,000,000		-1,386,000,000	-940,000,000	-366,000,000
net cash from financing activities																													-1,408,000,000	-611,000,000		-448,000,000	-1,034,000,000	-504,000,000		-1,784,000,000	-1,243,000,000	-792,000,000		-1,523,000,000	-959,000,000	-566,000,000		-1,208,000,000	-585,000,000	402,000,000		-1,001,000,000	-1,007,000,000	-478,000,000		-1,473,000,000	-1,226,000,000	-262,000,000
effect of exchange rate changes on cash and cash equivalents																													-6,000,000
change in cash and cash equivalents																													136,000,000	354,000,000		72,000,000	59,000,000	107,000,000		-64,000,000	-50,000,000	111,000,000		22,000,000	107,000,000	20,000,000		101,000,000	244,000,000	436,000,000		-221,000,000	-243,000,000	-111,000,000		99,000,000	145,000,000	98,000,000
cash and cash equivalents at beginning of period																													732,000,000	732,000,000		646,000,000	646,000,000	646,000,000		741,000,000	741,000,000	741,000,000		566,000,000	566,000,000	566,000,000		414,000,000	414,000,000	414,000,000		705,000,000	705,000,000	705,000,000		373,000,000	373,000,000	373,000,000
cash and cash equivalents at end of period																													868,000,000	1,086,000,000		718,000,000	705,000,000	753,000,000		677,000,000	691,000,000	852,000,000		588,000,000	673,000,000	586,000,000		515,000,000	658,000,000	850,000,000		484,000,000	462,000,000	594,000,000		472,000,000	518,000,000	471,000,000
interest payments																													873,000,000	549,000,000		1,383,000,000	834,000,000	540,000,000		1,339,000,000	767,000,000	490,000,000		1,349,000,000	810,000,000	487,000,000		1,441,000,000	899,000,000	523,000,000		1,464,000,000	909,000,000	533,000,000		1,404,000,000	854,000,000	517,000,000
income tax payments																													411,000,000			911,000,000	387,000,000			890,000,000	558,000,000			864,000,000	581,000,000			758,000,000	517,000,000			476,000,000	226,000,000
long-term debt, less net debt issuance costs of 158 and 164																														31,594,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 350,987,500 shares in 2018 and 350,091,600 shares in 2017																														4,000,000
income tax payments (refunds)																														11,000,000																32,000,000						428,000,000	141,000,000
accounts receivables																															6,501,000,000	5,980,000,000	5,782,000,000	5,664,000,000	5,826,000,000	5,503,000,000	5,669,000,000	5,880,000,000	5,889,000,000	5,827,000,000	5,804,000,000	5,928,000,000	5,694,000,000	5,524,000,000	5,472,000,000	5,489,000,000	5,208,000,000	4,924,000,000	4,915,000,000	4,877,000,000	4,672,000,000	4,598,000,000	4,485,000,000	4,878,000,000	4,533,000,000	3,925,000,000	3,946,000,000	4,060,000,000	3,832,000,000	3,636,000,000	3,769,000,000	3,878,000,000	3,692,000,000	3,499,000,000	3,680,000,000	3,870,000,000
long-term debt, less net debt issuance costs of 164 and 170																															32,858,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 350,091,600 shares—2017 and 370,535,900 shares—2016																															4,000,000
balances, december 31, 2014																															420,478,000				420,478,000				420,478,000				420,478,000,000
long-term debt, less net debt issuance costs of 171 and 170																																32,751,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 356,979,800 shares in 2017 and 370,535,900 shares in 2016																																4,000,000
benefit from doubtful accounts																																3,104,000,000	1,833,000,000	760,000,000		2,392,000,000	1,552,000,000	790,000,000		2,839,000,000	1,681,000,000	646,000,000		2,337,000,000	1,579,000,000	851,000,000		2,732,000,000	1,777,000,000	754,000,000		2,666,000,000	1,835,000,000	794,000,000
losses on retirement of debt																																39,000,000				4,000,000				125,000,000	125,000,000			226,000,000
legal claim costs																																				33,000,000	22,000,000	12,000,000		77,000,000				78,000,000	78,000,000	78,000,000
long-term debt, less net debt issuance costs of 179 and 170																																	31,448,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 362,895,000 shares in 2017 and 370,535,900 shares in 2016																																	4,000,000
long-term debt, less net debt issuance costs of 165 and 170																																		31,302,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 368,694,700 shares in 2017 and 370,535,900 shares in 2016																																		4,000,000
losses (gains) on sales of facilities																																		-1,000,000				1,000,000						-20,000,000	-32,000,000	-21,000,000		13,000,000				-4,000,000
income tax refunds																																		-3,000,000				-76,000,000												-185,000,000				-25,000,000
long-term debt, less net debt issuance costs of 170 and 167																																			31,160,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 370,535,900 shares — 2016 and 398,738,700 shares — 2015																																			4,000,000
stockholders’ deficit attributable to hca holdings, inc.																																			-7,302,000,000	-7,763,000,000	-8,107,000,000	-7,556,000,000	-7,599,000,000	-7,294,000,000	-7,406,000,000	-7,620,000,000	-7,894,000,000	-7,384,000,000	-7,990,000,000	-7,828,000,000	-8,270,000,000	-8,376,000,000	-8,823,000,000	-9,323,000,000	-9,660,000,000	-7,859,000,000	-8,243,000,000	-8,613,000,000	-8,258,000,000	-10,194,000,000	-8,681,000,000	-8,930,000,000	-11,926,000,000
balances, december 31, 2013																																			439,604,000				439,604,000				439,604,000,000				439,604,000,000
long-term debt, less net debt issuance costs of 178 and 167																																				31,225,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 376,140,800 shares in 2016 and 398,738,700 shares in 2015																																				4,000,000
long-term debt, less net debt issuance costs of 173 and 167																																					31,228,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 380,061,600 shares in 2016 and 398,738,700 shares in 2015																																					4,000,000
long-term debt, less net debt issuance costs of 179 and 167																																						30,328,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 393,650,000 shares in 2016 and 398,738,700 shares in 2015																																						4,000,000
deferred income taxes																																								412,000,000	376,000,000	304,000,000	366,000,000	320,000,000	500,000,000	492,000,000	489,000,000	400,000,000	401,000,000	385,000,000	385,000,000	322,000,000	323,000,000	226,000,000	594,000,000	643,000,000	894,000,000	916,000,000	931,000,000	1,045,000,000	1,126,000,000	1,181,000,000	1,192,000,000	1,099,000,000	1,032,000,000	988,000,000
long-term debt, less net debt issuance costs of 167 and 219																																							30,255,000,000		28,363,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 398,738,700 shares — 2015 and 420,477,900 shares — 2014																																							4,000,000
balances, december 31, 2012																																							443,200,000				443,200,000,000				443,200,000,000				443,200,000,000
long-term debt, less net debt issuance costs of 160 and 219																																								28,375,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 412,638,300 shares in 2015 and 420,477,900 shares in 2014																																								4,000,000
decrease in cash from operating assets and liabilities:
income tax benefits																																								231,000,000	197,000,000	38,000,000		119,000,000	75,000,000	50,000,000		70,000,000	61,000,000	36,000,000		82,000,000	71,000,000	49,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 416,348,900 shares in 2015 and 420,477,900 shares in 2014																																									4,000,000
long-term debt, less debt issuance costs of 220 and 219																																										27,406,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 419,179,100 shares in 2015 and 420,477,900 shares in 2014																																										4,000,000
distributions to stockholders																																										-6,000,000		-7,000,000	-7,000,000	-7,000,000		-13,000,000	-10,000,000	-10,000,000		-983,000,000	-982,000,000	-982,000,000
income tax (refunds) payments																																										-118,000,000
deferred loan costs																																											219,000,000	221,000,000	230,000,000	271,000,000	237,000,000	250,000,000	264,000,000	274,000,000	290,000,000	266,000,000	281,000,000	292,000,000	290,000,000	297,000,000	332,000,000	354,000,000	374,000,000	371,000,000	391,000,000	411,000,000	418,000,000	436,000,000	444,000,000	452,000,000
long-term debt																																											29,307,000,000	27,426,000,000	27,942,000,000	27,883,000,000	27,590,000,000	27,389,000,000	26,744,000,000	27,170,000,000	27,495,000,000	25,182,000,000	25,732,000,000	26,061,000,000	25,645,000,000	25,871,000,000	24,631,000,000	24,820,000,000	27,633,000,000	25,383,000,000	25,769,000,000	25,874,000,000	24,824,000,000	25,279,000,000	26,351,000,000	26,151,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 420,477,900 shares — 2014 and 439,604,000 shares — 2013																																											4,000,000
balances, december 31, 2011																																											437,478,000,000				437,478,000,000				437,478,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 433,378,700 shares in 2014 and 439,604,000 shares in 2013																																												4,000,000
changes in operating assets and liabilities																																												-2,945,000,000	-2,151,000,000	-1,561,000,000		-3,319,000,000	-2,335,000,000	-1,294,000,000		-2,923,000,000	-1,927,000,000	-1,384,000,000
amortization of deferred loan costs																																												33,000,000	23,000,000	14,000,000		41,000,000	28,000,000	13,000,000		44,000,000	29,000,000	14,000,000
disposition of hospitals and health care entities																																												38,000,000	32,000,000	23,000,000		31,000,000	31,000,000	1,000,000		17,000,000	6,000,000	1,000,000
issuance of long-term debt																																												3,502,000,000	3,502,000,000	3,502,000,000						1,350,000,000	1,350,000,000	1,350,000,000
net change in revolving credit facilities																																												-160,000,000	340,000,000	-2,440,000,000		630,000,000	-20,000,000	390,000,000		-875,000,000	-820,000,000	-470,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 431,372,800 shares in 2014 and 439,604,000 shares in 2013																																													4,000,000
loss on retirement of debt																																													226,000,000			17,000,000	17,000,000	17,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 444,201,100 shares in 2014 and 439,604,000 shares in 2013																																														4,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 439,604,000 shares — 2013 and 443,200,200 shares — 2012																																															4,000,000
balances, december 31, 2010																																															427,459,000,000				427,459,000,000
issuance of common stock																																															87,719,000,000				87,719,000,000
consolidation of acquired controlling interest in equity investment
reclassification of equity securities with contingent redemption rights
adjustment to the acquired controlling interest in equity investment
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 447,573,400 shares in 2013 and 443,200,200 shares in 2012																																																4,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 447,066,900 shares in 2013 and 443,200,200 shares in 2012																																																	4,000,000
losses on sales of facilities																																																	12,000,000	16,000,000			3,000,000	1,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 445,856,200 shares in 2013 and 443,200,200 shares in 2012																																																		4,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 443,200,200 shares — 2012 and 437,477,900 shares — 2011																																																			4,000,000
balances, december 31, 2009																																																			426,341,000,000
contributions
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 441,383,000 shares in 2012 and 437,477,900 shares in 2011																																																				4,000,000
pay-in-kind interest
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 440,483,600 shares in 2012 and 437,477,900 shares in 2011																																																					4,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 438,354,100 shares in 2012 and 437,477,900 shares in 2011																																																						4,000,000
equity securities with contingent redemption rights																																																											141,000,000	144,000,000	144,000,000	144,000,000	147,000,000	147,000,000	155,000,000	154,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 437,477,900 shares — 2011 and 427,458,800 shares — 2010																																																							4,000,000
investments of insurance subsidiary																																																								545,000,000	515,000,000	590,000,000	642,000,000	665,000,000	646,000,000	1,146,000,000	1,166,000,000	1,371,000,000	1,322,000,000	1,302,000,000
goodwill																																																								2,701,000,000	2,719,000,000	2,705,000,000	2,693,000,000	2,610,000,000	2,583,000,000	2,561,000,000	2,577,000,000	2,596,000,000	2,594,000,000	2,579,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 436,483,900 shares in 2011 and 427,458,800 shares in 2010																																																								4,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 517,094,100 shares in 2011 and 427,458,800 shares in 2010																																																									5,000,000
common stock 0.01 par; authorized 1,800,000,000 shares; outstanding 515,614,300 shares in 2011 and 427,458,800 shares in 2010																																																										5,000,000
common stock 0.01 par; authorized 125,000,000 shares — 2010 and 2009; outstanding 94,885,500 shares — 2010 and 94,637,400 shares — 2009																																																											1,000,000
common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,644,100 shares in 2010 and 94,637,400 shares in 2009																																																												1,000,000
stockholders’ deficit attributable to hca inc.																																																												-10,259,000,000	-10,525,000,000	-10,313,000,000	-8,986,000,000	-9,279,000,000	-9,486,000,000	-9,888,000,000
common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,638,800 shares in 2010 and 94,637,400 shares in 2009																																																													1,000,000
common stock 0.01 par; authorized 125,000,000 shares; outstanding 94,626,100 shares in 2010 and 94,637,400 shares in 2009																																																														1,000,000
common stock 0.01 par; authorized 125,000,000 shares — 2009 and 2008; outstanding 94,637,400 shares — 2009 and 94,367,500 shares — 2008																																																															1,000,000
common stock .01 par; authorized 125,000,000 shares; outstanding 94,614,500 shares in 2009 and 94,367,500 shares in 2008																																																																1,000,000
common stock .01 par; authorized 125,000,000 shares; outstanding 94,409,800 shares in 2009 and 94,367,500 shares in 2008																																																																	1,000,000
common stock .01 par; authorized 125,000,000 shares; outstanding 94,378,600 shares in 2009 and 94,367,500 shares in 2008																																																																		1,000,000

We provide you with 20 years of balance sheets for HCA Healthcare stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as asset and liabilities, payables and receivables, long debts and short debts, cash and inventories, expenses and profits. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of HCA Healthcare. Explore the full financial landscape of HCA Healthcare stock with our expertly curated balance sheets.

The information provided in this report about HCA Healthcare stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.